Skip to main content
Drimble Delaware

Pfizer to absorb Mylan, creating generic giant

NEW YORK (AP) - Pfizer is buying Mylan in an all-stock deal and combining the $10 billion generic pharmaceutical company with its own off-patent branded and...

More from Delaware Non-Local Sources